Serotonergic-postsynaptic receptors modulate gripping-induced immobility episodes in male taiep rats

José R Eguibar1, M C Cortés, M L Ita

  • 1Instituto de Fisiología, Benemérita Universidad Autónoma de Puebla, México. jeguibar@siu.buap.mx

Insights

Taiep rats, a model for narcolepsy, exhibit immobility episodes influenced by serotonin receptors. Specific serotonin agonists like +/-DOI reduced these episodes, suggesting potential therapeutic applications for narcolepsy.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Genetics

Background:

  • Taiep rats display a progressive demyelination and motor syndrome, resembling hypomyelination.
  • These rats exhibit REM-like sleep patterns and disorganized sleep-wake cycles during immobility, suggesting a model for narcolepsy-cataplexy.

Purpose of the Study:

  • To investigate the role of postsynaptic serotonin receptors in gripping-induced immobility episodes (IEs) in Taiep rats.
  • To explore potential therapeutic targets for narcolepsy-cataplexy.

Main Methods:

  • Administration of specific postsynaptic serotonin agonists (+/-DOI, alpha-methyl-5HT) and antagonists (ketanserine, metergoline) to Taiep rats.
  • Analysis of gripping-induced immobility episodes (frequency and duration).
  • Polysomnographic recordings to assess sleep-wake patterns and awakening time.

Main Results:

  • The serotonin agonist +/-DOI decreased the frequency and duration of gripping-induced IEs.
  • Nonspecific agonist alpha-methyl-5HT did not significantly affect IE frequency.
  • Serotonin antagonists showed a biphasic effect on IE frequency and duration.
  • +/-DOI administration led to increased awakening time and reduced slow wave and REM sleep.

Conclusions:

  • Postsynaptic serotonin receptors modulate gripping-induced immobility episodes in Taiep rats.
  • These findings correlate with observations in human narcolepsy, where serotonin-reuptake inhibitors improve cataplexy.
  • Specific serotonin agonists may offer a potential therapeutic strategy for human narcolepsy patients.